dr. morris on treatment advances made in braf-mutated mcrc
Published 4 years ago • 214 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
4:23
sequencing strategies in braf-mutated mcrc
-
9:28
new therapy options for braf-mutated mcrc
-
1:35:47
braf-mutated mcrc: from diagnosis to treatment
-
6:18
overcoming acquired resistance mechanisms in braf mcrc
-
4:54
case 1: braf-mutated metastatic colorectal cancer
-
4:23
the ras-raf pathway: new cancer research
-
![regorafenib in management of colorectal cancer – video abstract [id 88825]](https://i.ytimg.com/vi/ZMhWfX9j594/mqdefault.jpg)
7:41
regorafenib in management of colorectal cancer – video abstract [id 88825]
-
5:10
mutational toolkit for metastatic colorectal cancer patients
-
2:18
prognosticating braf-mutant mcrc
-
0:58
dr. morris on the role of immunotherapy in metastatic crc
-
6:01
beacon trial: triplet therapy in braf v600e–mutated mcrc
-
1:06
dr. cercek on targeted strategies in braf-mutant mcrc
-
29:45
keynote lecture 4: the braf pathway in crc?
-
2:28
the evolving treatment paradigm for braf v600e-mutant mcrc
-
1:13
dr. morris on the design of the cobra trial in stage ii colon cancer
-
3:03
braf: from gene to cancer therapy
-
1:51
dr. eng discusses the beacon crc study in braf-mutated crc
-
2:24
real-world management of patients with braf-v600e mcrc
-
1:45
breakwater: encorafenib plus cetuximab in patients with braf v600e-mutant mcrc
-
1:04
dr. marshall on the importance of testing for braf mutations in mcrc
-
2:16
dr. morris discusses optimizing treatment in crc based on patients oligometastatic status
-
0:54
dr. kopetz on safety data from beacon crc trial in braf v600e-mutant mcrc